GB202111193D0 - Pharmaceutical compounds - Google Patents
Pharmaceutical compoundsInfo
- Publication number
- GB202111193D0 GB202111193D0 GBGB2111193.5A GB202111193A GB202111193D0 GB 202111193 D0 GB202111193 D0 GB 202111193D0 GB 202111193 A GB202111193 A GB 202111193A GB 202111193 D0 GB202111193 D0 GB 202111193D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compounds
- pharmaceutical
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2111193.5A GB202111193D0 (en) | 2021-08-03 | 2021-08-03 | Pharmaceutical compounds |
| PCT/EP2022/071674 WO2023012153A1 (en) | 2021-08-03 | 2022-08-02 | Valosin-containing protein (vcp/p97) inhibitors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2111193.5A GB202111193D0 (en) | 2021-08-03 | 2021-08-03 | Pharmaceutical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB202111193D0 true GB202111193D0 (en) | 2021-09-15 |
Family
ID=77651261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB2111193.5A Ceased GB202111193D0 (en) | 2021-08-03 | 2021-08-03 | Pharmaceutical compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB202111193D0 (en) |
| WO (1) | WO2023012153A1 (en) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| WO1998004689A1 (en) | 1995-07-31 | 1998-02-05 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
| US6218529B1 (en) | 1995-07-31 | 2001-04-17 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
| BRPI0618042A2 (en) | 2005-11-04 | 2011-08-16 | Wyeth Corp | uses of a rapamycin and herceptin, product, pharmaceutical package, and, pharmaceutical composition |
| CA2879789C (en) | 2012-07-20 | 2019-08-20 | Cleave Biosciences, Inc. | Fused pyrimidines as inhibitors of p97 complex |
| SG11201605699QA (en) * | 2014-01-20 | 2016-08-30 | Cleave Biosciences Inc | FUSED PYRIMIDINES AS INHIBITORS OF p97 COMPLEX |
| US20200360386A1 (en) * | 2017-12-30 | 2020-11-19 | Unity Biotechnology, Inc. | Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways for Selective Removal of Senescent Cells in the Treatment of Age Related Conditions |
-
2021
- 2021-08-03 GB GBGB2111193.5A patent/GB202111193D0/en not_active Ceased
-
2022
- 2022-08-02 WO PCT/EP2022/071674 patent/WO2023012153A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023012153A1 (en) | 2023-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201911928D0 (en) | Pharmaceutical compounds | |
| IL276232A (en) | Pharmaceutical compounds | |
| GB202008961D0 (en) | Pharmaceutical composition | |
| GB201810245D0 (en) | Pharmaceutical compounds | |
| GB202020191D0 (en) | Pharmaceutical compounds | |
| GB201911944D0 (en) | Pharmaceutical compounds | |
| GB201810239D0 (en) | Pharmaceutical compounds | |
| GB201819961D0 (en) | Pharmaceutical compounds | |
| IL291570A (en) | Pharmaceutical compounds | |
| GB201914910D0 (en) | Pharmaceutical compounds | |
| GB202010409D0 (en) | Pharmaceutical compounds | |
| GB201819960D0 (en) | Pharmaceutical compounds | |
| GB201801562D0 (en) | Pharmaceutical compounds | |
| GB201800378D0 (en) | Pharmaceutical compounds | |
| GB202200753D0 (en) | Pharmaceutical compounds | |
| GB201816369D0 (en) | Pharmaceutical compounds | |
| GB202010408D0 (en) | Pharmaceutical compounds | |
| GB201915932D0 (en) | Pharmaceutical compounds | |
| GB201915273D0 (en) | Pharmaceutical compounds | |
| GB202117969D0 (en) | Pharmaceutical compounds | |
| GB202111193D0 (en) | Pharmaceutical compounds | |
| GB202104097D0 (en) | Pharmaceutical compounds | |
| GB202102602D0 (en) | Pharmaceutical compounds | |
| GB202007163D0 (en) | Pharmaceutical compounds | |
| GB202003646D0 (en) | Pharmaceutical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |